How valid is a prescription-based multimorbidity index (Rx-risk) in predicting mortality in the Outcomes and Multimorbidity In Type 2 diabetes (OMIT) study? A nation-wide registry-based cohort study from Norway

How valid is a prescription-based multimorbidity index (Rx-risk) in predicting mortality in the Outcomes and Multimorbidity In Type 2 diabetes (OMIT) study? A nation-wide registry-based cohort study from Norway

Objective The prescription-based Rx-risk index has previously been developed to measure multimorbidity. We aimed to adapt and evaluate the validity of the Rx-risk index in prediction of mortality among persons with type 2 diabetes.Design Registry-based study.Setting Adults with type 2 diabetes in No...

Full description

Bibliographic Details
Main Authors: Anne Karen Jenum, Jannicke Igland, Marjolein Memelink Iversen, Jan Ivar Røssberg, Ragnhild B Strandberg, Tore Julsrud Berg, Esben Selmer Buhl, Rachel Forster
Format: Article
Language:English
Published: BMJ Publishing Group 2024-03-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/14/3/e077027.full

Internet

https://bmjopen.bmj.com/content/14/3/e077027.full

Similar Items